A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases

HPB

Volumn 16, Issue 2, 2014, Pages 101-108

  Lam, Vincent W T ^a,b   Laurence, Jerome M ^a   Pang, Tony ^a,b   Johnston, Emma ^a,b   Hollands, Michael J ^a,b   Pleass, Henry C C ^a,b   Richardson, Arthur J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; HUMAN; LIVER RESECTION; MORBIDITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; RECURRENCE RISK; REVIEW; SYSTEMATIC REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892572172     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12083     Document Type: Review

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. McMillan DC, McArdle CS,. (2007) Epidemiology of colorectal liver metastases. Surg Oncol 16: 3-5.
3. Van Cutsem E, Köhne C-H, Hitre E, Zaluski J, Chang Chien C-R, Makhson A, et al. (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360: 1408-1417.
4. Chua TC, Saxena A, Chu F, Zhao J, Morris DL,. (2011) Predictors of cure after hepatic resection of colorectal liver metastases: an analysis of actual 5- and 10-year survivors. J Surg Oncol 103: 796-800.
5. Pulitano C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G, et al. (2010) What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB 12: 244-249.
6. Tomlinson JS, Jarnagin WR, Dematteo RP, Fong Y, Kornprat P, Gönen M, et al. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25: 4575-4580.
7. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD,. (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93: 872-878.
8. Law WL, Choi HK, Lee YM, Ho JW,. (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14: 2559-2566.
9. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, et al. (2007) Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14: 3481-3491.
10. Hillingsø JG, Wille-Jørgensen P,. (2009) Staged or simultaneous resection of synchronous liver metastases from colorectal cancer-a systematic review. Colorectal Dis 11: 3-10.
11. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
12. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien P-A,. (2012) Chemotherapy before liver resection of colorectal metastases. Ann Surg 255: 237-247.
13. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Third Symposium on Systematic Reviews: beyond the Basics. Oxford, July 2000.
14. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62: e1-34.
15. National Health and Medical Research Council. (1999) A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra, ACT: AusInfo.
16. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, et al. (2008) The 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 25: 430-435.
17. Verhoef C, van der Pool AEM, Nuyttens JJ, Planting AST, Eggermont AMM, de, Wilt JHW,. (2009) The liver-first approach for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 52: 23-30.
18. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, et al. (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210: 934-941.
19. De Jong MC, van Dam RM, Maas M, Bemelmans MHA, Olde Damink SWM, Beets GL, et al. (2011) The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB 13: 745-752.
20. van der Pool AEM, de Wilt JHW, Lalmahomed ZS, Eggermont AMM, Ijzermans JNM, Verhoef C,. (2010) Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg 97: 383-390.
21. Radunz S, Heuer M, Trarbach T, Mathe Z, Baba HA, Paul A, et al. (2011) Long-term survival after 'liver first' approach for locally advanced rectal cancer and synchronous liver metastases. Int J Colorectal Dis 26: 1219-1220.
22. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA,. (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13: 1261-1268.
23. Ayez N, Van Der Pool A, Burger JWA, Eggermont AMM, Ijzermans JNM, Verhoef C,. (2011) The long term results of the liver first approach in patients with locally advanced rectal cancer and synchronous liver metastases. Eur J Cancer 47: S409.
24. Van Der Pool AE, De Wilt JH, Nuytens JJ, Eggermont AM, Verhoef C,. (2010) The liver-first approach for patients with locally advanced rectal cancer and synchronous liver metastases: long-term results. J Clin Oncol 28 (15 Suppl): e14027.
25. Zitt M,. (2011) Bowel first? Simultaneous resection? Liver first? Treatment options in patients with colorectal cancer and resectable synchronous liver metastases. Mag Eur Med Oncol 4: 79-81.
26. Damjanov N, Weiss J, Haller DG,. (2009) Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 14: 963-969.
27. Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, et al. (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27: 3379-3384.
28. Lambert LA, Colacchio TA, Barth RJ,. (2000) Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 135: 473-479.
29. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938-2947.
30. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237.
31. Folprecht G, Gruenberger T, Bechstein WO, Raab R, Lordick F, Hartmann JT, et al. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjavant chemotherapy with cetuximan: the CELIM randomized phase 2 trial. Lancet Oncol 11: 38-47.
32. Masi G, Loupakis F, Salvatore L, Fornaro L, Cremolini C, Cupini S, et al. (2010) Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 11: 845-852.
33. Temple LKF, Hsieh L, Wong WD, Saltz L, Schrag D,. (2004) Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 22: 3475-3484.
34. Stillwell AP, Buettner PG, Siu SK, Stitz RW, Stevenson AR, Ho YH,. (2011) Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer. Dis Colon Rectum 54: 535-544.
35. McCahill LE, Yothers G, Sharif S, Petrelli NJ, Lai LL, Bechar N, et al. (2012) Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol 30: 3223-3228.
36. Watt AM, Faragher IG, Griffin TT, Rieger NA, Maddern GJ,. (2007) Self-expanding metallic stents for relieving malignant colorectal obstruction. Ann Surg 246: 24-30.
37. Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J, et al. (2003) Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 52: 568-573.
38. Lam VWT, Spiro C, Laurence JM, Johnston E, Hollands MJ, Pleass HCC, et al. (2012) A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann Surg Oncol 19: 1292-1301.
39. Aloia TA, Fahy BN,. (2008) A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer 7: 197-201.
40. Abbott DE, Cantor SB, Hu C-Y, Aloia TA, You YN, Nguyen S, et al. (2012) Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215: 262-270.
41. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C,. (1999) Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28: 1-9.
42. Bravata DM, Olkin I,. (2001) Simple pooling versus combining in meta-analysis. Eval Health Prof 24: 218-230.